A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

DRUG

Insulin Glargine

Administered SC

DRUG

Insulin Degludec

Administered SC

Trial Locations (30)

44150

Unidad de Investigaci�n Cl�nica Cardiometabolica de Occidente, Guadalajara

44650

Unidad de patologia Clinica, Guadalajara

64460

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

100730

Beijing Peking Union Medical College Hospital, Beijing

110004

Shengjing Hospital of China Medical University, Shenyang

130021

The First Hospital of Jilin University, Changchun

130041

No.2 Hospital Affiliated to Jilin University, Changchun

150001

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

200062

Shanghai Putuo District Center Hospital, Shanghai

200072

Shanghai Tenth People's Hospital, Shanghai

200092

Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

210000

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing

210006

The First Hospital of Nanjing, Nanjing

210029

Jiangsu Province Hospital, Nanjing

211166

Sir Run Run Hospital of Nanjing Medical University, Nanjing

212000

Affiliated Hospital of Jiangsu University, Zhenjiang

213003

Changzhou No.2 People's Hospital, Changzhou

215004

The Second Affiliated Hospital of Soochow University, Suzhou

230011

The Second People's Hospital of Hefei, Hefei

410011

The Second Xiangya Hospital of Central South University, Changsha

415003

The First People's Hospital of Changde City, Changde

471003

The First Affiliated Hospital of Henan University of Science &Technology, Luoyang

510120

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

515041

Shantou University Medical College No.2 Affiliated Hospital, Shantou

518039

Shenzhen Second People's Hospital, Shenzhen

523059

Dongguan people's hospital, Dongguan

610041

West China Hospital Sichuan University, Chengdu

C1056ABJ

Centro de Investigaciones Metabólicas (CINME), CABA

C1120AAC

Centro Médico Viamonte, CABA

X5008HHW

Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC, Córdoba

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03952130 - A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter